| Leukemia studied in …STUDIED_INderived10 of 8,437show all (up to 200) |
|---|
| → studied in | NCT03059485Phase 2 · active not recruiting DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission · condition mapped ALIAS · 8,437 trials mapped (2,127 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03187288Phase 1 · completed Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS · condition mapped CURATED_BROADER · 8,437 trials mapped (2,127 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03597321Phase 2 · active not recruiting Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML · condition mapped CURATED_BROADER · 8,437 trials mapped (2,127 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03679650Phase 1 · active not recruiting Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients · condition mapped ALIAS · 8,437 trials mapped (2,127 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739814Phase 2 · recruiting Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 8,437 trials mapped (2,127 active) | — | — | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03802695Phase 1 · recruiting A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped CURATED_BROADER · 8,437 trials mapped (2,127 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05424562terminated A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada · condition mapped CURATED_BROADER · 8,437 trials mapped (2,127 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05621291NA · recruiting A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph... · condition mapped CURATED_BROADER · 8,437 trials mapped (2,127 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768711Phase 2 · active not recruiting Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) · condition mapped ALIAS · 8,437 trials mapped (2,127 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738368Phase 2 · suspended Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 8,437 trials mapped (2,127 active) | — | — | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |